{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:03:38Z","timestamp":1790309018043,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.biopha.2018.01.108","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T08:31:41Z","timestamp":1518769901000},"page":"198-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Immune cells involved in the pathogenesis of ankylosing spondylitis"],"prefix":"10.1016","volume":"100","author":[{"given":"Alireza","family":"Rezaiemanesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Abdolmaleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Abdolmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Aghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Dadgar","family":"Pakdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Fatahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Soleimanifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Zavvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Nicknam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9783","key":"10.1016\/j.biopha.2018.01.108_bib0005","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/BOR.0b013e32833ac5cc","article-title":"New approaches to diagnosis and classification of axial and peripheral spondyloarthritis","volume":"22","author":"Rudwaleit","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"issue":"10089","key":"10.1016\/j.biopha.2018.01.108_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.biopha.2018.01.108_bib0020","doi-asserted-by":"crossref","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","article-title":"Ankylosing spondylitis: an overview","volume":"61","author":"Sieper","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.berh.2006.03.005","article-title":"Non-major-histocompatibility-complex genetics of ankylosing spondylitis","volume":"20","author":"Brown","year":"2006","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0030","first-page":"294","article-title":"Association between endoplasmic reticulum aminopeptidase-1 (ERAP-1) and susceptibility to ankylosing spondylitis in Iran","volume":"11","author":"Mahmoudi","year":"2012","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2018.01.108_bib0035","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","article-title":"Association scan of 14,500 nsSNPs in four common diseases identifies variants involved in autoimmunity","volume":"39","author":"Wtccc","year":"2007","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrrheum.2009.258","article-title":"Disease modification in ankylosing spondylitis","volume":"6","author":"Maksymowych","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/reum.2015.50551","article-title":"Cytokine profiles in axial spondyloarthritis","volume":"53","author":"Madej","year":"2015","journal-title":"Reumatologia"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/03009742.2014.956142","article-title":"Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study","volume":"44","author":"Sveaas","year":"2015","journal-title":"Scand. J. Rheumatol."},{"issue":"22","key":"10.1016\/j.biopha.2018.01.108_bib0055","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1007\/s00018-015-2005-0","article-title":"Human dendritic cell subsets and function in health and disease","volume":"72","author":"O\u2019Keeffe","year":"2015","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/imm.12117","article-title":"Human dendritic cell subsets","volume":"140","author":"Collin","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2018.01.108_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2013.09.023","article-title":"Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases","volume":"19","author":"Qu","year":"2014","journal-title":"Int. J. Infect. Dis.: IJID"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/JVI.79.1.17-27.2005","article-title":"Plasmacytoid dendritic cells: linking innate and adaptive immunity","volume":"79","author":"McKenna","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1440-1711.2000.00888.x","article-title":"Dendritic cells: immunological sentinels with a central role in health and disease","volume":"78","author":"Stockwin","year":"2000","journal-title":"Immunol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kev245","article-title":"Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation","volume":"55","author":"Wright","year":"2016","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.biopha.2018.01.108_bib0095","first-page":"501653","article-title":"Ankylosing spondylitis: from cells to genes","volume":"2013","author":"Zambrano-Zaragoza","year":"2013","journal-title":"Int. J. Inflamm."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13075-014-0417-0","article-title":"Monocyte-derived dendritic cells from HLA-B27+ axial spondyloarthritis (SpA) patients display altered functional capacity and deregulated gene expression","volume":"16","author":"Talpin","year":"2014","journal-title":"Arthr. Res. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0105","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s10753-011-9373-x","article-title":"Phenotype of resting and activated monocyte-derived dendritic cells grown from peripheral blood of patients with ankylosing spondylitis","volume":"35","author":"Slobodin","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2018.01.108_bib0110","series-title":"Current Protocols in Immunology","article-title":"Quantitative assessment of macrophage functions in repair and fibrosis","author":"Wynn","year":"2011"},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0115","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.cell.2014.04.016","article-title":"Tissue-specific signals control reversible program of localization and functional polarization of macrophages","volume":"157","author":"Okabe","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/path.1044","article-title":"Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy","volume":"196","author":"Baeten","year":"2002","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0125","doi-asserted-by":"crossref","first-page":"R569","DOI":"10.1186\/ar1698","article-title":"Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis","volume":"7","author":"Kruithof","year":"2005","journal-title":"Arthr. Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/art.1780390116","article-title":"Synovial tissue macrophage populations and articular damage in rheumatoid arthritis","volume":"39","author":"Mulherin","year":"1996","journal-title":"Arthr. Rheum."},{"issue":"9","key":"10.1016\/j.biopha.2018.01.108_bib0135","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.22854","article-title":"Targeting of Gr-1+,CCR2++ monocytes in collagen-induced arthritis","volume":"56","author":"Bruhl","year":"2007","journal-title":"Arthr. Rheum."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0140","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3899\/jrheum.090348","article-title":"Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers","volume":"36","author":"Bresnihan","year":"2009","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"38","author":"Braun","year":"1995","journal-title":"Arthr. Rheum."},{"issue":"9","key":"10.1016\/j.biopha.2018.01.108_bib0150","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K","article-title":"Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis","volume":"43","author":"Barrera","year":"2000","journal-title":"Arthr. Rheum."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1016523914161","article-title":"Anti-inflammatory effect of granulocyte and monocyte adsorption apheresis in a rabbit model of immune arthritis","volume":"26","author":"Kashiwagi","year":"2002","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.biopha.2018.01.108_bib0160","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1159\/000374026","article-title":"IL-4 modulates macrophage polarization in ankylosing spondylitis","volume":"35","author":"Lin","year":"2015","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.108_bib0165","first-page":"1","article-title":"Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23","author":"Rezaiemanesh","year":"2016","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis","volume":"30","author":"Mei","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cei.12670","article-title":"The interleukin (IL)-23\/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment","volume":"183","author":"Jethwa","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2018.01.108_bib0180","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaut.2012.05.006","article-title":"Regulatory NK cells in autoimmune disease","volume":"39","author":"Tian","year":"2012","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.biopha.2018.01.108_bib0190","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0200","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/s10165-009-0160-6","article-title":"A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis","volume":"19","author":"Aramaki","year":"2009","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.108_bib0210","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/art.24556","article-title":"Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus","volume":"60","author":"Park","year":"2009","journal-title":"Arthr. Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0215","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2133.2003.05319.x","article-title":"Circulating natural killer cells in psoriasis","volume":"149","author":"Cameron","year":"2003","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.108_bib0220","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/intimm\/dxh270","article-title":"The involvement of NK cells in ankylosing spondylitis","volume":"17","author":"Azuz-Lieberman","year":"2005","journal-title":"Int. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0225","first-page":"193","article-title":"Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients","volume":"8","author":"Mousavi","year":"2009","journal-title":"Iran J. Allergy Asthma Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.108_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7439\/ijbr.v6i5.2004","article-title":"Natural killer and natural killer T cells as a prognostic factor for rheumatoid arthritis and ankylosing spondylitis","volume":"6","author":"Akal\u0131n","year":"2015","journal-title":"Int. J. Biomed. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0235","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B","article-title":"Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study","volume":"44","author":"Baeten","year":"2001","journal-title":"Arthr. Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0240","first-page":"19","article-title":"Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis","volume":"7","author":"Nicknam","year":"2008","journal-title":"Iran J. Allergy Asthma Immunol."},{"issue":"14","key":"10.1016\/j.biopha.2018.01.108_bib0245","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0161-5890(02)00030-5","article-title":"A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors","volume":"38","author":"Boyington","year":"2002","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0250","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/eji.1830260845","article-title":"Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones","volume":"26","author":"Luque","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0255","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.27332","article-title":"Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis","volume":"62","author":"Diaz-Pena","year":"2010","journal-title":"Arthr. Rheum."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0260","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar1988","article-title":"Contribution of KIR3DL1\/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 caucasian populations","volume":"8","author":"Lopez-Larrea","year":"2006","journal-title":"Arthr. Res. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0265","first-page":"88","article-title":"Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis","volume":"7","author":"Mousavi","year":"2010","journal-title":"Iran. J. Immunol.: IJI"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0270","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/s10165-012-0692-z","article-title":"Association of KIR genotype with susceptibility to HLA-B27-positive ankylosing spondylitis","volume":"23","author":"Wang","year":"2013","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0275","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/ard.2008.095927","article-title":"Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis","volume":"68","author":"Harvey","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.108_bib0280","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10875-010-9444-z","article-title":"Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis","volume":"30","author":"Jiao","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.108_bib0285","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.humimm.2008.04.012","article-title":"Activating KIR genes are associated with ankylosing spondylitis in Asian populations","volume":"69","author":"Diaz-Pena","year":"2008","journal-title":"Hum. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.01.108_bib0290","doi-asserted-by":"crossref","first-page":"A50","DOI":"10.1136\/annrheumdis-2016-209124.121","article-title":"A6.09 Nk cells as biosensors for responsiveness to etanercept in ankylosing spondylitis (Morbus Bechterew)","volume":"75","author":"Schulte-Wrede","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2018.01.108_bib0295","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3899\/jrheum.070839","article-title":"Intracytoplasmic cytokine expression and T cell subset distribution in the peripheral blood of patients with ankylosing spondylitis","volume":"35","author":"Szanto","year":"2008","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0300","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3899\/jrheum.110862","article-title":"In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis","volume":"39","author":"Limon-Camacho","year":"2012","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0305","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3892\/etm.2014.2046","article-title":"T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis","volume":"9","author":"Wang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2018.01.108_bib0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cyto.2016.01.012","article-title":"Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis","volume":"81","author":"Wang","year":"2016","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0315","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2249.2004.02617.x","article-title":"Increased CCR4 expression on circulating CD4+ T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus","volume":"138","author":"Yang","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2018.01.108_bib0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cyto.2016.01.012","article-title":"Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis","volume":"81","author":"Wang","year":"2016","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.biopha.2018.01.108_bib0325","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.61.11.968","article-title":"Atopic disorders in ankylosing spondylitis and rheumatoid arthritis","volume":"61","author":"Rudwaleit","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0330","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11882-014-0489-6","article-title":"Update on ankylosing spondylitis: current concepts in pathogenesis","volume":"15","author":"Smith","year":"2015","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0335","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cyto.2015.01.003","article-title":"Update on the role of interleukin 17 in rheumatologic autoimmune diseases","volume":"75","author":"Konya","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2018.01.108_bib0340","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13075-016-0949-6","article-title":"IL-23\/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients","volume":"18","author":"Milanez","year":"2016","journal-title":"Arthr. Res. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0345","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","article-title":"Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides","volume":"58","author":"Jandus","year":"2008","journal-title":"Arthr. Rheum."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.108_bib0350","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","article-title":"Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis","volume":"60","author":"Shen","year":"2009","journal-title":"Arthr. Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0355","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10875-012-9774-0","article-title":"Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-alpha therapy","volume":"33","author":"Xueyi","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.108_bib0360","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1517\/14712598.2016.1167183","article-title":"Secukinumab (AIN457) in the treatment of ankylosing spondylitis","volume":"16","author":"Braun","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/14728214.2013.752815","article-title":"Emerging drugs for axial spondyloarthritis including ankylosing spondylitis","volume":"18","author":"Busquets-Perez","year":"2013","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14728214.2013.749857","article-title":"Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis?","volume":"18","author":"Wendling","year":"2013","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0375","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/13543784.2016.1116519","article-title":"An overview of investigational new drugs for treating ankylosing spondylitis","volume":"25","author":"Wendling","year":"2016","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"9906","key":"10.1016\/j.biopha.2018.01.108_bib0380","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.biopha.2018.01.108_bib0385","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","article-title":"Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)","volume":"73","author":"Poddubnyy","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0390","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0395","first-page":"246","article-title":"Th22 cells contribution in immunopathogenesis of rheumatic diseases","volume":"14","author":"Azizi","year":"2015","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0400","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.gene.6363716","article-title":"IL-TIF\/IL-22: genomic organization and mapping of the human and mouse genes","volume":"1","author":"Dumoutier","year":"2000","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0405","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imr.12027","article-title":"IL-22, not simply a Th17 cytokine","volume":"252","author":"Rutz","year":"2013","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0410","doi-asserted-by":"crossref","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","article-title":"IL-22 is increased in active Crohn\u2019s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration","volume":"290","author":"Brand","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0415","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jdermsci.2010.03.018","article-title":"Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy","volume":"58","author":"Lo","year":"2010","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0420","doi-asserted-by":"crossref","first-page":"e31000","DOI":"10.1371\/journal.pone.0031000","article-title":"Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0425","first-page":"488","article-title":"Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies","volume":"56","author":"El-Zayadi","year":"2017","journal-title":"Rheumatology (Oxford, England)"},{"issue":"12","key":"10.1016\/j.biopha.2018.01.108_bib0430","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/art.27699","article-title":"Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response","volume":"62","author":"Ciccia","year":"2010","journal-title":"Arthr. Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0435","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/icb.2015.90","article-title":"TCR usage, gene expression and function of two distinct FOXP3(+)treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO","volume":"94","author":"Ye","year":"2016","journal-title":"Immunol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.108_bib0440","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1177\/147323001103900543","article-title":"Inverse correlation between CD4+ CD25high CD127low\/- regulatory T-cells and serum immunoglobulin A in patients with new-onset ankylosing spondylitis","volume":"39","author":"Zhao","year":"2011","journal-title":"J. Int. Med. Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.01.108_bib0445","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jbspin.2015.03.003","article-title":"Regulatory T cells in ankylosing spondylitis and the response after adalimumab treatment","volume":"82","author":"Liao","year":"2015","journal-title":"Joint Bone Spine: revue du rhumatisme"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0450","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10875-009-9356-y","article-title":"Association of CTLA4 gene polymorphism in Iranian patients with ankylosing spondylitis","volume":"30","author":"Azizi","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0455","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2008.088120","article-title":"Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls","volume":"68","author":"Zhang","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2015.27.1.1","article-title":"Abnormal B lymphocyte activation and function in systemic sclerosis","volume":"27","author":"Yoshizaki","year":"2015","journal-title":"Ann. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.108_bib0465","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/art.20174","article-title":"Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis","volume":"50","author":"Baeten","year":"2004","journal-title":"Arthr. Rheum."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.108_bib0470","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.1780400206","article-title":"Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity","volume":"40","author":"Tak","year":"1997","journal-title":"Arthr. Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0475","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.108_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2015.27.1.1","article-title":"Abnormal B lymphocyte activation and function in systemic sclerosis","volume":"27","author":"Yoshizaki","year":"2015","journal-title":"Ann. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.108_bib0485","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3899\/jrheum.101257","article-title":"Interferon-\u03b3 contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies","volume":"39","author":"Feng","year":"2012","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.108_bib0490","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.berh.2011.10.005","article-title":"B-cell therapies in established rheumatoid arthritis","volume":"25","author":"Leandro","year":"2011","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"18","key":"10.1016\/j.biopha.2018.01.108_bib0495","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.lfs.2013.09.003","article-title":"Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis","volume":"93","author":"Niu","year":"2013","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.biopha.2018.01.108_bib0500","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.autrev.2016.06.001","article-title":"Detection of novel diagnostic antibodies in ankylosing spondylitis: an overview","volume":"15","author":"Quaden","year":"2016","journal-title":"Autoimmun. Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217359334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217359334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T18:06:03Z","timestamp":1761242763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217359334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":100,"alternative-id":["S0753332217359334"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.108","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune cells involved in the pathogenesis of ankylosing spondylitis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}